Written by Jay Campbell
[Disclaimer: This article is for educational purposes only. Always consult with a qualified healthcare provider before starting any peptide protocol.]
Cagrilintide vs Tirzepatide: Which one of these appetite suppressants is better?
Many people in the health optimization space are asking the same question right now.
Here’s the short answer: Tirzepatide is the better compound overall because it works through multiple metabolic pathways in addition to reducing appetite.
The longer answer, as you’ll see in this article, is Retatrutide blows them both out of the water for fat loss.
Let me show you how.
Quick Takeaways
- No completed head-to-head trials exist where Cagrilintide is directly compared to Tirzepatide.
- Tirzepatide is a dual GLP-1/GIP agonist — it addresses appetite, insulin sensitivity, fat metabolism, and energy expenditure simultaneously
- Cagrilintide targets amylin receptors in the brain for powerful appetite suppression, but without the broader metabolic benefits seen with Tirzepatide.
- Retatrutide is the triple GLP-1/GIP/glucagon agonist producing up to 24% body weight reduction in 48 weeks, surpassing both compounds through three simultaneous metabolic pathways
- Right now, the evidence clearly favors Tirzepatide over Cagrilintide as a standalone metabolic therapy, but Retatrutide makes this comparison obsolete.
Why Tirzepatide Wins Over Cagrilintide
The answer fundamentally comes down to their respective mechanisms of action.
Tirzepatide: Multi-Pathway Metabolic Optimization
Tirzepatide is a dual incretin receptor agonist that activates both GLP-1 and GIP receptors simultaneously.
GLP-1 suppresses appetite, slows gastric emptying, and improves insulin sensitivity.
GIP enhances insulin secretion, may improve fat metabolism, and influences energy expenditure.
Tirzepatide represents a two-stage approach to metabolic optimization, in which your body’s ability to process fuel, store fat, and regulate blood sugar dramatically improves.
Multiple Phase 3 clinical trials in human subjects show sustained weight loss averaging 15-22% of body weight at higher doses, along with major HbA1c reductions, improved glycemic control, visceral fat reduction, and better lipid profiles.
Cagrilintide: Powerful But Narrow
Cagrilintide is a dual amylin and calcitonin receptor agonist (DACRA) that binds AMY1R, AMY2R, AMY3R, and CTR in the brainstem.
Its primary effect is appetite suppression, which happens through the activation of satiety centers in the area postrema and nucleus of the solitary tract.
The end result is a powerful reduction in hunger and food cravings.
Potentially TOO powerful if you’re not careful with the dosing (i.e. it can shut appetite down completely, which is a real risk for anyone trying to maintain muscle mass and hit protein targets).
But while Cagrilintide is indeed a valuable tool, it is therapeutically more narrow than Tirzepatide as it primarily manipulates appetite signaling in the brain… and that’s about it.
Tirzepatide does a lot more than make you less hungry.
As I just said before, this fat loss peptide:
- Improves insulin sensitivity
- Enhances fat metabolism through GIP receptor agonism
- Reduces visceral fat
- Addresses the metabolic dysfunction that CAUSED the weight gain in the first place
Cagrilintide makes you not want to eat, while Tirzepatide does that in addition to changing how your body handles what you eat.
This makes the latter a more holistically helpful compound in the context of comprehensive metabolic optimization.
Retatrutide Is Superior to Both Tirzepatide and Cagrilintide
Now let me tell you what makes this entire debate a potentially pointless endeavor….
Retatrutide is a triple receptor agonist targeting the GLP-1, GIP, AND glucagon receptors simultaneously.
This is a major upgrade from Semaglutide targeting the GLP-1 receptor, or Tirzepatide targeting the GLP-1 and GIP receptors.
The glucagon receptor activation leads to a direct increase in energy expenditure, something neither Tirzepatide nor Cagrilintide can do (at least not as effectively).
So in addition to suppressing appetite and improving insulin sensitivity, you are now burning more energy at rest.
The Phase 2 trial results speak for themselves: up to 24% body weight reduction at the highest dose (12mg/week) in 48 weeks, with 25% of patients losing 30% or more of their starting weight.
These results are directly comparable to what can be achieved through bariatric surgery!
And since the weight loss did not plateau at the study cutoff, even greater results are possible with extended treatment.
Women lost more weight than men (28.5% body weight loss vs 21.9% body weight loss, respectively) but both sexes saw dramatically superior results compared to anything produced by Tirzepatide or Cagrilintide monotherapy.
For pure fat loss potency through multi-pathway metabolic intervention, Retatrutide is currently the most powerful compound in existence.
Cagrilintide and Tirzepatide Combination Therapy: Is It Worth It?
If Cagrilintide suppresses appetite through the amylin pathway and tirzepatide optimizes metabolism through the GLP-1 and GIP pathways, stacking them makes theoretical sense.
You’re suppressing appetite and delaying gastric emptying through two separate mechanisms of action, plus you’re technically tapping into to a triple receptor agonist therapy.
But stacking them carelessly will lead to gastrointestinal misery, over-suppression of appetite over-suppression, and a consequently higher risk of under-eating protein.
If you’re not eating enough to support muscle retention, you WILL lose lean mass and this is non-negotiable.
The more studied combination is CagriSema, a combination therapy pairing Cagrilintide with Semaglutide at the same time.
Two of the REDEFINE Phase 3 trials examining the use of CagriSemaare now largely complete.
REDEFINE 1 confirmed superior weight loss with CagriSema versus Semaglutide alone in adults with obesity.
REDEFINE 2, focused on type 2 diabetes, showed a mean 13.7–14.25% body weight reduction over 68 weeks with CagriSema compared to roughly 3% with placebo.
Novo Nordisk has begun regulatory submissions, although though CagriSema remains investigational and is not yet available for prescription.
As for the combination of Cagrilintide and Tirzepatide, it hasn’t been formally studied yet.
Regardless, the fundamentals are non-negotiable if you go down this route: Medical supervision, conservative titration on both compounds, tracked protein intake, and consistent resistance training.
This combination should NOT be regarded as a beginner-level peptide stack!
Where Cagrilintide Still Has a Role
I’m not dismissing Cagrilintide entirely, as it does have a specific use case.
If you are someone who still experiences significant food noise while using GLP-1 receptor agonists, or requires deeper appetite suppression beyond what incretin pathways provide, Cagrilintide’s targeting of the amylin pathway can help with both circumstances.
As we’ve seen with Novo Nordisk’s CagriSema (cagrilintide + semaglutide), which targets the amylin and GLP-1 pathways simultaneously, it outperforms Semaglutide alone.
Ongoing Phase 3 trials are comparing CagriSema head-to-head with tirzepatide.
Tirzepatide still takes the cake over Cagrilintide for comprehensive metabolic optimization, and Retatrutide is superior to either option.
Safety Considerations
All three compounds discussed in this article slow gastric emptying, which means the gastrointestinal side effects are common across the board.
Tirzepatide’s safety profile is well characterized: Nausea (20-30%), vomiting (5-10%), diarrhea and constipation are the most common adverse events.
The severity and frequency of these adverse events is dose-dependent, but both can be reduced with slower stepwise dose titration.
Cagrilintide may have a lower incidence of vomiting than GLP-1 receptor agonists, but it still has the potential to over-suppress your appetite.
Retatrutide’s Phase 2 safety data looks great, but it’s still awaiting publication of its Phase 3 results and eventual FDA approval.
For all of these peptides: Start low, titrate slowly, maintain protein intake, and train with resistance.
The promise of fat loss means nothing if you lose muscle in the process.
Sourcing
If you’re exploring any of these compounds, sourcing matters enormously.
The peptide market is flooded with underdosed, contaminated, and counterfeit products.
BioLongevity Labs is the industry benchmark for USA-manufactured, third-party-tested research peptides.
The company carries Cagrilintide and other metabolic compounds at the highest purity standards available.
Use code JAYC at checkout for 15% off!
Cagrilintide vs Tirzepatide: The Bottom Line
Tirzepatide remains one of the better options for peptide-assisted fat loss and metabolic health.
It’s a multi-pathway compound that addresses appetite, insulin sensitivity, fat metabolism, and glycemic control simultaneously.
Cagrilintide is a powerful appetite suppression tool that operates through the amylin pathway, but it’s a narrower intervention.
Its best use case may be as an add-on agent to be used with GLP-1 agonists, and not as a standalone alternative to Tirzepatide.
Retatrutide is the compound that changes the conversation entirely.
The activation of GLP-1, GIP, and glucagon receptors produces fat loss results that surpass both Tirzepatide and Cagrilintide.
And it’s only going to get more data supporting its use as the Phase 3 trials reach completion.
For a foundational education on the subject of peptides, read my article about Peptides Demystified.
For peptide-assisted fat loss strategies, check out my guide to the best peptides for weight loss.
Isn’t It Time You Became Fully Optimized To Live Longer and Stronger?
Join my #1 online membership group, Fully Optimized Health to receive guidance from me and an elite group of more than 800 male and female biohackers (who all started out just like you)
And don’t forget to check out our other premium educational content dedicated to helping you fully optimize your health:
Quantum Peptides – the A-to-Z system for anyone (newbies & pros alike) desiring to master peptide use for the first time and forever.
Quantum Testosterone – the A-to-Z system for Men & Women to learn to optimize their hormones for explosive energy, lean muscle, and timeless vitality.
The Ultimate GLP-1 Video Masterclass – how to PROPERLY utilize the world’s most powerful weight loss drugs for enhanced fat loss and overall longevity.
The Modern Woman’s Peptide Course – a must-have resource for any woman seeking to become more feminine, sexier, leaner, and healthier through the use of peptides.
Life Enhanced – Unlock the secrets to TOTAL Mind-Body-Spirit Optimization as Hunter Williams and I teach you how to live at the tip of the spear.
30 Days 2 Shredz – Reprogram Your Mind and Body for Maximum Fat Loss in Minimum Time with our Optimized Fasting Protocol
Monica Campbell’s 3 Day PMF Video Training Program – Ignite unbreakable strength, sculpt lean muscle, and conquer workouts fearlessly with my wife Monica’s 3 Day Video training course.
Positive Muscle Failure Video Training Program – Learn how to lift weights correctly for maximum muscle in minimum time while building the physique of your dreams.
See you on the inside!
